Introduction
Hepatocellular carcinoma is the fifth most common type of cancer and the third most common cause of cancer-related mortality in the world. Over 80% of HCC develops in cirrhotic liver, and is mainly attributable to chronic viral infection with hepatitis B or C. The great majority of HCC cases occur in developing countries with a very high incidence in Asia and Sub-Sahara Africa. However, its incidence is increasing in Japan, United States, and other western countries with the rise of infection with hepatitis C (Nordenstedtet al., 2010 and Yang and Roberts, 2010).
HCC has a rising incidence in Egypt mostly due to high prevalence of viral hepatitis and its complications. It ranks second and sixth most common cancer among men and women respectively (Omar et al., 2013).
Theoretically, the best treatment for HCC is liver transplantation, which offers the potential to both resect the entire potentially tumor-bearing liver and eliminate the cirrhosis if present The present study is an epidemiologic retrospective one that aimed at identification of different treatment modalities of hepatocellular carcinoma in Assiut Governorate and to identify the factors that affect the choice and effectiveness of each modality.
Patients and Methods
The present study is an epidemiologic retrospective one that aimed at determining the bulk of the problem in our area and to identify the results of different treatment modalities.It was carried out on all patients presented to liver hospital and clinical oncology unit in Assuit University Hospital and were diagnosed as HCC during the period from 2012 to 2014
All patients 'files were reviewed for clinical, laboratory, imaging data and staging according to Child-Pugh classification system, The different modalities of treatment were reviewed and recorded includingSurgery For resectable tumors and locoregional treatment for unresectable tumorsandmetastatic disease.
All files also were reviewed for assessment after the end of treatment and the response were defined according to WHO criteria as: complete response (CR), partial response (PR),minimal response (MR)and progressive disease (PD). 
Results
As shown in table1, The majority of patients were males (79.2%); Patients were equally distributed around the age of 60yrs (52% above 60 and 48% were below); Hepatitis C-V was associated with more than 90% of cases; and Child Pugh score of A in 60% of cases and the primary diagnosis of a single lesion was made in 60% of cases. In table 2 and in figure 1 ; the frequency of different treatment options is displayed where TACE was the most commonly used option followed by local ablation and chemotherapy There is high statistically significant difference between child pugh score of the patient and TACE as a modality of treatment (P value 0,0001) but no statistically significant difference with other modalities of treatment (table 3) There is high statistically significant difference between size of the tumor (more or less than 5 cm) and local ablation (P value 0.001), also significant with best supportive care (P value 0.001) as modalities of treatment. but no statistically significant difference with other modalities (table 4) HCV infection confers the highest risk of HCC in patients with cirrhosis, with an annual incidence ranged between 2% and 8 % (Bruix and Sherman, 2005). While the incidence of HBV-related HCC has decreased after the initiation of a universal vaccination program (El-Serag 2011).
In our study: In about 60%of cases child pugh score was A, while it was B in about 35%,C in about 5% of the cases, this can simply be explained as the majority of cases were studied at el Rajhi hospital which were admitted to hospital with criteria consistent with planning for major or minor surgical procedure that included patients in relatively good general condition or in early stages of disease.
AFP was less than 400 in 56% of the cases of the present study,most worldwide studies recommend AFP level with high cutoff points as 400ng/ml to be a good prognostic In the present study we found highly significant difference between tumor size and sex(p value 0.001) this could be explained by increased exposure to risk factors in males; hepatitis C or B, smoking, alcohol,Yu MW et al., (2005)also genetics and sex hormonesas estrogen and androgen were found to play a role in hepatocarcinogenesis(Nagasue N et al., 1985).It maybe also explained by the common belief that males in poor communities are usually late complainers than women.
Ahighly significant difference was found between tumor size and Child Pugh score (p value 0.009).butno statistically significant difference between multiplicity of lesion and either hepatitis or child pugh score.
In our study, there was no statistically significant difference between alpha feto protein neither with tumor size nor multiplicity. This was in disagreement with other studies as that suggests strong correlation between AFP and size >5cm (Abbasiet al., 2012)
As regards different treatment modalities applied in Assiut university hospitals,we found that; TACE and Local ablation were the most common modalities of treatment (27% and 23%) while the least commonly used modality was surgery and BSC (13 % for each) on the other hand21% of HCC patients were subjected to chemotherapy "weekly gemzar". This generally agreed with Weledjiet al., (2014) who states that local ablation (using either radiofrequency ablation or percutaneous ethanol injection) and TACE are the 1 st treatment option in HCC patients specially in cases with early stages HCC but not suitable for surgery and those cases represent the largest proportion of HCC patients, and also safe and effective option.
In our study we found that complete response was the most frequent result of resection/transplantation arm (58% of the patients) followed by TACE and local ablation this generally agreed with the report of theJournal of Hepatology(2012) with some limitations: it stated that liver resection is the treatment of choice for patients with maintained underlying liver structure and function and for patients with solitary tumors, if these conditions were applied complete response will be achieved in most cases, however the risk of recurrence is high on the long term .While with local ablation with radiofrequency or percutaneous ethanol injection it was considered the standard care for early stage patients with tumors not suitable for surgery,radiofrequency ablation is recommended in most instances as the main ablative therapy in tumors less than 5 cm. Ethanol injection is recommended in cases where radiofrequency ablation is not technically feasible(around 10-15%). In tumors <2 cm, with early Child pugh score, both techniques achievecomplete responses in more than 90% of cases with good long-term outcome. Whether they can beconsidered as competitive alternatives to resection is uncertain Progression response was most commonly met with Best Supportive Care arm (76.5%) followed by chemotherapy (55%) while it was 0% with resection arm. Journal of Hepatology(2012)stated that best supportive careusually results in disease progression due to the original advanced disease.thus,it can't be involved in trials. Concerning chemotherapy, Journal of Hepatologyalso agreed with our study in that chemotherapy is not a recommended modality of treatment for HCC, the only standard systemic treatment is Sorafenib which couldn't be included in our study due to financial issues.
In this study, According to Child Pugh score the different treatment modalities were almost similarily used in Child's A and B while in Child's C the best supportive care was significantly commonly used.this was in agreement with Journal of Hepatology(2012) which clarified that almost all modalities of treatment whether surgery, local ablation, TACE or even systemic chemotherapy requires relatively good general condition and early Child's score (A,B) to be able to get satisfactory outcome, for patients with Child's score C, the only possible treatment option is Best supportive care.
In our study there was high statistically significant difference between tumor size of 5 cm or less and local ablation: this is simply explained by the fact that in the interventional procedure of local ablation patients are selected preoperatively to have tumor size less than 5 cm. On the other hand a significant value (P value 0.001) with best supportive care and tumor sizes larger than 5 cm is expected with this line. Also there was no statistically significant The current study shows that in single lesion/cases the most commonly used modalities were TACE and local ablation,this disagreed with (EASL-EORTC Clinical Practice Guidelines,2012) which approved liver resection as the first treatment choice for solitary tumor lesions,this disagreement maybe explained by the fact that in our community locoregional procedures are more safe and less complicated.In cases with multiple lesions, local ablation and chemotherapy were most commonly used. This agreed with (EASL-EORTC Clinical Practice Guidelines,2012) which stated that locoregional treatment is the available option for multinodular tumor cases, chemotherapy is not recommended as a treatment choice in the guidelines but systemic treatment (sorafenib) is given tocases with tumor lesions beyond locoregional procedures, sorafenib couldn't be administered by patients in our study due to financial issues.
In Conclusion;
The available treatment modalities in our area depend on many factors such as tumour size; multiplicity; Child-Pugh score and presence hepatitis in addition to the availability of surgical treatment options like liver-transplantation. As an area of low resources and low socio-economic standards: this seems to play an important role and would affect the timing of HCC detection;progress of investigations and ability to provide our patients with optimum care as much as can be done: finally all these factors would add to the prognostic module when the case is going to be counseled for best treatment options.
